Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1999 1
2000 2
2002 2
2003 4
2004 5
2005 7
2006 7
2007 7
2008 6
2009 8
2010 12
2011 11
2012 9
2013 8
2014 11
2015 7
2016 9
2017 5
2018 7
2019 7
2020 11
2021 7
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

139 results
Results by year
Filters applied: . Clear all
Page 1
Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
Cicero AFG, Allkanjari O, Busetto GM, Cai T, Larganà G, Magri V, Perletti G, Robustelli Della Cuna FS, Russo GI, Stamatiou K, Trinchieri A, Vitalone A. Cicero AFG, et al. Arch Ital Urol Androl. 2019 Oct 2;91(3). doi: 10.4081/aiua.2019.3.139. Arch Ital Urol Androl. 2019. PMID: 31577095 Free article. Review.
In parallel, epidemiological studies demonstrated that diet may play an important role on incidence and development of prostatic diseases. The Mediterranean diet is rich of elements with anti-oxidant properties that act as a protective factor for prostatic cancer
In parallel, epidemiological studies demonstrated that diet may play an important role on incidence and development of prostatic dise …
Immune evasion in cancer: Mechanistic basis and therapeutic strategies.
Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, Lichtor T, Decker WK, Whelan RL, Kumara HMCS, Signori E, Honoki K, Georgakilas AG, Amin A, Helferich WG, Boosani CS, Guha G, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Keith WN, Bilsland A, Bhakta D, Halicka D, Fujii H, Aquilano K, Ashraf SS, Nowsheen S, Yang X, Choi BK, Kwon BS. Vinay DS, et al. Semin Cancer Biol. 2015 Dec;35 Suppl:S185-S198. doi: 10.1016/j.semcancer.2015.03.004. Epub 2015 Mar 25. Semin Cancer Biol. 2015. PMID: 25818339 Free article. Review.
Cancer immune evasion is a major stumbling block in designing effective anticancer therapeutic strategies. ...In addition, tumors exploit several immunological processes such as targeting the regulatory T cell function or their secretions, antigen presentation, modifyin
Cancer immune evasion is a major stumbling block in designing effective anticancer therapeutic strategies. ...In addition, tumors exp
Diet and lifestyle considerations for patients with prostate cancer.
Zuniga KB, Chan JM, Ryan CJ, Kenfield SA. Zuniga KB, et al. Urol Oncol. 2020 Mar;38(3):105-117. doi: 10.1016/j.urolonc.2019.06.018. Epub 2019 Jul 18. Urol Oncol. 2020. PMID: 31327752 Free PMC article. Review.
PURPOSE: To review the literature and provide recommendations on diet and lifestyle considerations in patients with prostate cancer using evidence from randomized controlled trials (RCTs) with additional considerations based on observational evidence. ...Few items h …
PURPOSE: To review the literature and provide recommendations on diet and lifestyle considerations in patients with prostate cance
Dietary Factors and Supplements Influencing Prostate Specific-Antigen (PSA) Concentrations in Men with Prostate Cancer and Increased Cancer Risk: An Evidence Analysis Review Based on Randomized Controlled Trials.
Grammatikopoulou MG, Gkiouras K, Papageorgiou SΤ, Myrogiannis I, Mykoniatis I, Papamitsou T, Bogdanos DP, Goulis DG. Grammatikopoulou MG, et al. Nutrients. 2020 Sep 29;12(10):2985. doi: 10.3390/nu12102985. Nutrients. 2020. PMID: 33003518 Free PMC article. Review.
The quest for dietary patterns and supplements efficient in down-regulating prostate-specific antigen (PSA) concentrations among men with prostate cancer (PCa) or increased PCa risk has been long. Several antioxidants, including lycopene, selenium, curcumin, …
The quest for dietary patterns and supplements efficient in down-regulating prostate-specific antigen (PSA) concentrations among men …
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study.
Keizman D, Frenkel M, Peer A, Kushnir I, Rosenbaum E, Sarid D, Leibovitch I, Mano R, Yossepowitch O, Margel D, Wolf I, Geva R, Dresler H, Rouvinov K, Rapoport N, Eliaz I. Keizman D, et al. Nutrients. 2021 Nov 28;13(12):4295. doi: 10.3390/nu13124295. Nutrients. 2021. PMID: 34959847 Free PMC article. Clinical Trial.
Optimal therapy of biochemically relapsed prostate cancer (BRPC) after local treatment is elusive. An established modified citrus pectin (PectaSol(), P-MCP), a dietary polysaccharide, is an established antagonist of galectin-3, a carbohydrate-bi …
Optimal therapy of biochemically relapsed prostate cancer (BRPC) after local treatment is elusive. An established modified
Synergistic and additive effects of modified citrus pectin with two polybotanical compounds, in the suppression of invasive behavior of human breast and prostate cancer cells.
Jiang J, Eliaz I, Sliva D. Jiang J, et al. Integr Cancer Ther. 2013 Mar;12(2):145-52. doi: 10.1177/1534735412442369. Epub 2012 Apr 24. Integr Cancer Ther. 2013. PMID: 22532035 Free article.
AIM: The objective of this study was to evaluate the combined effect of a known galectin-3 inhibitor, PectaSol-C modified citrus pectin (MCP), and 2 novel integrative polybotanical compounds for breast and prostate health, BreastDefend (BD) and Pros
AIM: The objective of this study was to evaluate the combined effect of a known galectin-3 inhibitor, PectaSol-C modified citrus
Suppression of growth and invasive behavior of human prostate cancer cells by ProstaCaid™: mechanism of activity.
Jiang J, Eliaz I, Sliva D. Jiang J, et al. Int J Oncol. 2011 Jun;38(6):1675-82. doi: 10.3892/ijo.2011.996. Epub 2011 Apr 4. Int J Oncol. 2011. PMID: 21468543
In the present study we have evaluated the anti-cancer effects of dietary supplement ProstaCaid (PC) which contains mycelium from medicinal mushrooms (Ganoderma lucidum, Coriolus versicolor, Phellinus linteus), saw palmetto berry, pomegranate, pumpkin …
In the present study we have evaluated the anti-cancer effects of dietary supplement ProstaCaid (PC) which contains mycelium f …
Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3'-Diindolylmethane.
Williams DE. Williams DE. Front Nutr. 2021 Oct 1;8:734334. doi: 10.3389/fnut.2021.734334. eCollection 2021. Front Nutr. 2021. PMID: 34660663 Free PMC article. Review.
The pharmacokinetics/pharmacodynamics of DIM have been studied in both rodents and humans and urinary DIM is a proposed biomarker of dietary intake of cruciferous vegetables. ...In humans much of the focus has been on chemoprevention of breast and prostate
The pharmacokinetics/pharmacodynamics of DIM have been studied in both rodents and humans and urinary DIM is a proposed biomar …
Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in Prostate Cancer.
Conti S, Vexler A, Hagoel L, Kalich-Philosoph L, Corn BW, Honig N, Shtraus N, Meir Y, Ron I, Eliaz I, Lev-Ari S. Conti S, et al. Integr Cancer Ther. 2018 Dec;17(4):1225-1234. doi: 10.1177/1534735418790382. Epub 2018 Jul 25. Integr Cancer Ther. 2018. PMID: 30043669 Free PMC article.
BACKGROUND: Radiotherapy is one of the primary therapies for localized prostatic carcinoma. Therefore, there is an emerging need to sensitize prostatic cancer cells to chemotherapy/radiotherapy. Modified citrus pectin (MCP) is an effectiv …
BACKGROUND: Radiotherapy is one of the primary therapies for localized prostatic carcinoma. Therefore, there is an emerging need to s …
Indole-3-carbinol and prostate cancer.
Sarkar FH, Li Y. Sarkar FH, et al. J Nutr. 2004 Dec;134(12 Suppl):3493S-3498S. doi: 10.1093/jn/134.12.3493S. J Nutr. 2004. PMID: 15570059 Review.
Because there is no effective treatment strategy for hormone-dependent and, most importantly, hormone-independent and metastatic prostate cancer, our strategies to sensitize prostate cancer cells to a chemotherapeutic agent by I3C and DIM is a n …
Because there is no effective treatment strategy for hormone-dependent and, most importantly, hormone-independent and metastatic prostate
139 results